Dr. Iskandar is recognized for his clinical expertise and experimental work in congenital diseases that alter CSF hydrodynamics, in particular hydrocephalus, Chiari malformations, and syringomyelia. Led by Dr. Iskandar and funded by the Theodore W. Batterman Family Foundation, the Wisconsin Hydrocephalus Group (WHP) of engineers, physicists, neurologists, and neurosurgeons aims to determine the etiology of ventricular shunt malfunction and optimize the devices used to treat it. As well, Dr. Iskandar directs a translational research laboratory previously funded by the NIH and the March of Dimes that has discovered an important link between single carbon folate and cobalamin metabolism, epigenetic influences, and axonal regeneration after central nervous system injury. Dr. Iskandar has served on national neurosurgical committees and boards, and currently serves as Vice-Chair of the Board of Directors of the American Board of Pediatric Neurological Surgery and as Chair of the AANS/CNS Section on Pediatric Neurosurgery.
Education & credentials
- Neurological Surgery
- University of Pennsylvania School of Medicine, Philadelphia, PA
Pediatric Neurosurgery, Children's Hospital of Alabama, Birmingham, AL
- Duke University Medical Center, Durham, NC
- Boston University Medical Center, Boston, MA
Research and publications
Dr. Iskandars's research contributions include optimizing the diagnosis and management of children with Chiari malformations and spinal dysraphism, pioneering imaging techniques aimed at minimizing the radiation exposure of children with hydrocephalus, and understanding the link between folate biochemistry, epigenetics, and central nervous system injury and repair.